MLVBX | VSTSX | MLVBX / VSTSX | |
Total Expense Ratio | 1.64 | 0.01 | 16,400% |
Annual Report Gross Expense Ratio | 1.69 | 0.01 | 16,900% |
Fund Existence | 12 years | 9 years | - |
Gain YTD | 5.347 | 6.427 | 83% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000 | 5000000000 | 0% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 358M | 1.82T | 0% |
Annual Yield % from dividends | 0.19 | 1.23 | 16% |
Returns for 1 year | -2.49 | 13.91 | -18% |
Returns for 3 years | 2.05 | 62.21 | 3% |
Returns for 5 years | 23.78 | 95.76 | 25% |
Returns for 10 years | 73.68 | N/A | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
MID | 66.51 | 0.61 | +0.93% |
American Century Mid Cap Gr Impact ETF | |||
BBC | 20.32 | 0.13 | +0.65% |
Virtus LifeSci Biotech Clinical Trls ETF | |||
EFFE | 21.87 | N/A | N/A |
Harbor Osmosis Emerging Markets Resource Efficient ETF | |||
DIVI | 35.72 | -0.02 | -0.06% |
Franklin Intl Core Div Tlt Idx ETF | |||
MHN | 9.85 | -0.07 | -0.71% |
Blackrock Muniholdings NEW York Quality Fund |